First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.
Johanna BendellPatricia LoRussoMichael James OvermanAnne M NoonanDong Wan KimJohn H StricklerSang-We KimStephen ClarkeThomas J GeorgePeter S GrimisonMinal BarveManik AminJayesh DesaiTrisha Michel Wise-DraperSteven EckYu JiangAnis A KhanYuling WuPhilip MartinZachary A CooperNairouz ElgeioushiNancy MuellerRakesh KumarSandip Pravin PatelPublished in: Cancer immunology, immunotherapy : CII (2023)
Clinicaltrials.gov, NCT02503774; date of registration, July 17, 2015.